{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:19:59Z","timestamp":1791519599274,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejso.2026.111490","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:18:42Z","timestamp":1771863522000},"page":"111490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative safety and tolerability of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with concurrent systemic therapy in the same admission as a bidirectional chemotherapy: A retrospective comparative study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-3643","authenticated-orcid":false,"given":"S.P.","family":"Somashekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Ashwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rohitkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.N.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0614-0027","authenticated-orcid":false,"given":"S.V.","family":"Vivek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-6784","authenticated-orcid":false,"given":"V.K.","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-9326","authenticated-orcid":false,"given":"E.S.","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Aboobacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Pugazhenthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-9563","authenticated-orcid":false,"given":"Ajinkya","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111490_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12957-019-1731-4","article-title":"Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study","volume":"17","author":"Klos","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111490_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"issue":"1","key":"10.1016\/j.ejso.2026.111490_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00384-025-04978-8","article-title":"Cytoreductive surgery for colorectal peritoneal metastasis in the era modern systemic therapies: a systematic review and meta-analysis of survival outcomes","volume":"40","author":"Kazi","year":"2025","journal-title":"Int J Colorectal Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2026.111490_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13193-023-01728-6","article-title":"Peritoneal mesothelioma: systematic review of hyperthermic intraperitoneal chemotherapy (HIPEC) protocol outcomes","volume":"14","author":"Kepenekian","year":"2023","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13193-016-0498-0","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) methodology, drugs and bidirectional chemotherapy","volume":"7","author":"Valle","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111490_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40265-025-02195-9","article-title":"A clinical pharmacological perspective on intraperitoneal chemotherapy","volume":"85","author":"Rietveld","year":"2025","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ejso.2026.111490_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/890450","article-title":"Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous cisplatin for diffuse malignant peritoneal mesothelioma","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111490_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib11","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0107","article-title":"Adjuvant pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) in resected high-risk Colon cancer patients - study protocol for the PIPAC-OPC3 trial. A prospective, controlled phase 2 study","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"12","key":"10.1016\/j.ejso.2026.111490_bib12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/cancers17121938","article-title":"Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) for peritoneal malignancies with palliative and bidirectional intent","volume":"17","author":"Marrelli","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ejso.2026.111490_bib13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"20","author":"Blanco","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111490_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2026.111490_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"14","author":"Robella","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111490_bib16","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e80","article-title":"Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis","volume":"28","author":"Hilal","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111490_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jso.21702","article-title":"Pharmacology of perioperative 5-fluorouracil","volume":"102","author":"Van der Speeten","year":"2010","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111490_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0753-3322(89)90003-6","article-title":"Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum","volume":"43","author":"Math\u00e9","year":"1989","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11605-017-3565-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedure for non-resectable peritoneal carcinomatosis (with video)","volume":"22","author":"Cazauran","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2026.111490_bib20","series-title":"Common terminology criteria for adverse events (CTCAE) v5.0","year":"2017"},{"key":"10.1016\/j.ejso.2026.111490_bib21","doi-asserted-by":"crossref","unstructured":"Khomiakov V, Ryabov A, Bolotina LV, Utkina A, Cheremisov V, Kolobaev I, et al. Bidirectional chemotherapy in gastric cancer (GC) with peritoneal carcinomatosis (PC) combining intravenous chemotherapy with intraperitoneal chemotherapy with low-dose cisplatin and doxorubicin administered as a pressurized aerosol: an open-label, phase II study. J Clin Oncol 35:JCO.2017.35.15_suppl.e15532.","DOI":"10.1200\/JCO.2017.35.15_suppl.e15532"},{"key":"10.1016\/j.ejso.2026.111490_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.4_suppl.99","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis (PIPAC-GA1)","volume":"35","author":"Struller","year":"2017","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2026.111490_bib23","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.3390\/jcm12216799","article-title":"PIPAC for gastrointestinal malignancies","volume":"12","author":"Daniel","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","article-title":"Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111490_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0248-8663(97)89966-3","article-title":"Oxaliplatine, acide folinique et 5-fluorouracile (folfox) en seconde ligne th\u00e9rapeutique du cancer colorectal m\u00e9tastas\u00e9. Le GERCOD [Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD]","volume":"18","author":"de Gramont","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ejso.2026.111490_bib26","doi-asserted-by":"crossref","first-page":"goaf040","DOI":"10.1093\/gastro\/goaf040","article-title":"Pressurized intraperitoneal aerosol chemotherapy in advanced gastric cancer with peritoneal metastases: a comprehensive meta-analysis of feasibility, efficacy, and safety","volume":"13","author":"Chen","year":"2025","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ejso.2026.111490_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.suronc.2020.05.006","article-title":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): a bidirectional approach for gastric cancer peritoneal metastasis","volume":"34","author":"Di Giorgio","year":"2020","journal-title":"Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111490_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/SAP.0b013e3181828141","article-title":"A review on bevacizumab and surgical wound healing: an important warning to all surgeons","volume":"62","author":"Gordon","year":"2009","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111490_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12885-020-6572-6","article-title":"Bidirectional treatment of peritoneal metastasis with pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) and systemic chemotherapy: a systematic review","volume":"20","author":"Ploug","year":"2020","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2026.111490_bib30","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111490_bib31","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.21873\/anticanres.13062","article-title":"No renal toxicity after repeated treatment with pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with unresectable peritoneal metastasis","volume":"38","author":"Larbre","year":"2018","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ejso.2026.111490_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.ejso.2026.111490_bib33","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.3390\/cancers17152580","article-title":"Advances in bidirectional therapy for peritoneal metastases: a systematic review of pressurized intraperitoneal aerosol chemotherapy (PIPAC) combined with systemic chemotherapy","volume":"17","author":"Robella","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejso.2026.111490_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejso.2022.07.024","article-title":"Hospitalization cost of pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"49","author":"Tidadini","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111490_bib35","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo na\u00efve upper gi-adenocarcinomas with peritoneal seeding - a phase II\/III trial of the AIO\/CAOGI\/ACO","volume":"3","author":"Oliver","year":"2018","journal-title":"Pleura Peritoneum"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:36:47Z","timestamp":1774697807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0748798326001095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111490","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative safety and tolerability of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with concurrent systemic therapy in the same admission as a bidirectional chemotherapy: A retrospective comparative study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111490"}}